Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-24

Clinical Trial Update: Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction

View source ↗

Summary

A safety follow-up clinical trial evaluating Cellgram-ED for erectile dysfunction after radical prostatectomy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cellgram-ED

Snippet

Sponsor: Pharmicell Co., Ltd. | Conditions: Erectile Dysfunction | Status: RECRUITING